You searched for metabolic diseases - Page 34 of 63

News and Trends 9 Apr 2019

French First-in-Class Diabetes Drug Nails Phase III Trial

…to the mitochondria, the structures that generate energy within cells, plays a key role in the progression of metabolic diseases. With this unique method of action, imeglimin has the potential…

April 9, 2019 - 3 minutesmins - By Jonathan Smith

Belgium biotech vc fund newton biocapital japan

News and Trends 18 Feb 2022

Belgian VC Fund Leads Investment Wave in Japanese Biotech

…and metabolic diseases. In 2017, Newton Biocapital launched its first VC fund, Newton Biocapital I (NBC I), worth €114M. The firm established startups including Epics Therapeutics and ChromaCure in Belgium,…

February 18, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

…acquire Embark Biotech and its lead asset targeting obesity and other cardiometabolic diseases, alongside entering a three-year research and development collaboration to discover and develop novel pharmaceuticals to treat obesity…

September 28, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 24 Nov 2022

Gene therapy approval “game changer” in hemophilia B treatment

…Hemgenix is worth the asking price of $3.5 million. This is especially the case for rare diseases with small patient pools. “Out of 25,000 male births in the U.S., ‘only’…

November 24, 2022 - 7 minutesmins - By Jonathan Smith

In Depth 20 Oct 2023

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

…short) are also often more receptive than large multinational corporations to focusing on neglected diseases, especially when those diseases remain endemic in their country or region.” Fortunately, things are starting…

October 20, 2023 - 10 minutesmins - By Willow Shah-Neville

In Depth 18 Jul 2022

Deep phenotyping brings accuracy to precision medicine

…not account for the level of complexity that underlies diseases and, as a result, fails to establish the causality of disease, instead focusing on one or few biomarkers that are…

July 18, 2022 - 8 minutesmins - By Sachin Rawat

News and Trends 23 Apr 2020

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

…Treg cell therapies for inflammatory and autoimmune diseases. Under the terms of the agreement, Mogrify will receive an undisclosed upfront payment from Sangamo and will also be eligible to receive…

April 23, 2020 - 3 minutesmins - By Laura Cowen

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

…recent outbreaks of diseases such as Ebola, SARS and now Covid-19 have been a wake-up call to both investors and governments about the importance of pandemic preparedness. As of May…

May 18, 2020 - 13 minutesmins - By Helen Albert

News and Trends 2 Jun 2022

Upstream Bio to target asthma as it launches with $200M financing

…program UPB-101, a clinical-stage monoclonal antibody targeting the thymic stromal lymphopoietin (TSLP) receptor. It added the investment will also help build a pipeline of assets to address immune-mediated diseases. The…

June 2, 2022 - 4 minutesmins - By Jim Cornall

astrazeneca asthma copd epigenetic targets

News and Trends 21 Jun 2016

UK Partnership is looking for new Epigenetic targets in Respiratory Disease

…for diseases like asthma. After partnering up with genomics elite for a new biobank, AstraZeneca is again preparing to tap into collaborations with academia. This time, the objective is to…

June 21, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 31 Oct 2022

Replay Bio launches HSV gene therapy company to target retinal eye disease

…addressing genetic eye diseases caused by large genes and genomic genes. “This will result in an increased variety of gene therapy options for patients with genetic eye diseases,” Mahajan said….

October 31, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 14 Sep 2022

Collaboration to explore gene therapy products for neurodegenerative disorders

Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop gene therapy proteins targeting protein degradation in neurodegenerative disorders. The IMN is a joint research…

September 14, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

French First-in-Class Diabetes Drug Nails Phase III Trial

Belgian VC Fund Leads Investment Wave in Japanese Biotech

Obesity drug success sparks biotech buying spree

Gene therapy approval “game changer” in hemophilia B treatment

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

Deep phenotyping brings accuracy to precision medicine

Mogrify Teams Up With Sangamo To Streamline Cell Immunotherapies

Will Covid-19 Change the Face of Vaccine Development?

Upstream Bio to target asthma as it launches with $200M financing

UK Partnership is looking for new Epigenetic targets in Respiratory Disease

Replay Bio launches HSV gene therapy company to target retinal eye disease

Collaboration to explore gene therapy products for neurodegenerative disorders

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!